EUVIMEDEUVIMED entdecken
Crossref

Unlocking Nature’s Pharmacy: Phytochemical investigation of Succisa pratensis

Z Anwar, C Gately, J O’Brien, S Nagar, H Sheridan, J J Walsh

Planta Medica · 01.03.2026 · 92 (03) · 317

DOI: 10.1055/s-0045-1815180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.03.2026. Verfasst von Z Anwar und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Succisa pratensis , or devil’s-bit scabious, is a member of the Caprifoliaceae family and found across Europe, western Siberia, and North Africa. Traditionally, it has been used in the British Isles to treat rheumatism, bruises, toothache, throat sores, dog bites, and scurvy, and in Ireland, it is particularly employed for treating skin problems like boils [ 1 ]. Previous studies have shown the plant’s diverse pharmacological potential, including antibacterial, antifungal, antioxidant, anti-inflammatory, and antiproliferative activities, especially in the methanolic extract of its leaves. Additionally, S. pratensis extract have been reported to reduce NF-κB activation and lower NF-κB and COX-2 gene expression in HepG2 cells [ 2 ] [ 3 ] [ 4 ]. Although some phytochemical analyses using LCMS and GCMS have been conducted, limited work has been done to isolate and characterise its active constituents. In this study, the methanolic extract of S. pratensis leaves was fractionated using chromatographic techniques, resulting in the isolation of 10 compounds, including scopoletin, scopolin, chlorogenic acid, and various dicaffeoyl quinic acid derivatives – 3,5-dicaffeoyl quinic acid, 3,4-dicaffeoyl quinic acid, 3,5-dicaffeoyl quinic acid methyl ester, 3,4-dicaffeoyl quinic acid methyl ester, along with secologanin and gentiopicroside. Structural confirmation was achieved through mass spectrometry and NMR spectroscopy. Notably, scopolin, secologanin derivatives, and dicaffeoyl quinic acid derivatives were isolated and characterised for the first time in S. pratensis . These findings contribute to the exploration of native Irish medicinal plants for bioactive compounds and enhance the understanding of S. pratensis ’s chemical constituents, highlighting its potential for future pharmacological applications. Publication History Article published online: 05 March 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Zitieren

APA

Anwar, Z., Gately, C., O’Brien, J., Nagar, S., Sheridan, H., & Walsh, J. J. (2026). Unlocking Nature’s Pharmacy: Phytochemical investigation of Succisa pratensis. Planta Medica, 92(03), 317. https://doi.org/10.1055/s-0045-1815180

Vancouver

Anwar Z, Gately C, O’Brien J, Nagar S, Sheridan H, Walsh JJ. Unlocking Nature’s Pharmacy: Phytochemical investigation of Succisa pratensis. Planta Medica. 2026;92(03):317. doi:10.1055/s-0045-1815180

BibTeX
@article{Anwar2026,
  author = {Anwar, Z and Gately, C and O’Brien, J and Nagar, S and Sheridan, H and Walsh, J J},
  title = {Unlocking Nature’s Pharmacy: Phytochemical investigation of Succisa pratensis},
  journal = {Planta Medica},
  year = {2026},
  volume = {92},
  number = {03},
  pages = {317},
  doi = {10.1055/s-0045-1815180}
}
Kostenlos starten →